What is Epocrates?
Epocrates, now an athenahealth service, functions as a premier developer of medical applications designed to streamline clinical decision-making. By offering a comprehensive suite of practice tools and health industry engagement platforms, the company addresses the complex information needs of healthcare providers. Its market position is defined by its ability to integrate seamlessly into the physician workflow, thereby enhancing diagnostic accuracy and operational efficiency within clinical settings. The platform serves as a bridge between medical data and actionable insights, facilitating better patient outcomes through technology-driven engagement.
How much funding has Epocrates raised?
Epocrates has raised a total of $138M across 4 funding rounds:
Series A
$10.8M
Series B
$35M
Series C
$6.4M
Stock Offering
$85.8M
Series A (1999): $10.8M, investors not publicly disclosed
Series B (2000): $35M led by Three Arch Partners, Sprout Group, Draper Fisher Jurvetson (DFJ), InterWest Partners, and Bay City Capital
Series C (2002): $6.4M supported by InterWest Partners, Bay City Capital, Draper Fisher Jurvetson (DFJ), Sprout Group, and Three Arch Partners
Stock Issuance/Offering (2011): $85.8M, investors not publicly disclosed
Key Investors in Epocrates
Draper Fisher Jurvetson (DFJ)
Draper Fisher Jurvetson is a prominent venture capital firm with a global reach and approximately $6 billion in capital commitments, known for backing industry-changing catalysts across multiple technology sectors.
Three Arch Partners
Three Arch Partners is a specialized investment firm focused on medical devices and healthcare services, actively assisting in the creation and development of clinical and market leaders.
Bay City Capital
Bay City Capital is a life sciences-focused venture capital firm that supports innovative companies through significant milestones, including FDA approvals and therapeutic advancements.
What's next for Epocrates?
Following its major strategic investment, Epocrates is well-positioned to further scale its clinical intelligence capabilities. The focus remains on deepening the integration of its tools within the broader athenahealth network, ensuring that physicians have real-time access to critical data. Future strategic initiatives will likely prioritize the expansion of its mobile-first medical resources and the enhancement of its health industry engagement modules. By leveraging its established user base and robust technological infrastructure, the company aims to continue setting the standard for point-of-care medical software, driving innovation in physician-facing digital health solutions.
See full Epocrates company page
